R. Alexandra Keith Procter & Gamble CO (PG) insider trading activity

R. Alexandra Keith is CEO - Beauty of PROCTER & GAMBLE Co. Currently has a direct ownership of 13,783 shares of PG, which is worth approximately $2.35 Million. The most recent transaction as insider was on Oct 22, 2024, when has been sold 1,992 shares (Common Stock) at a price of $170.0 per share, resulting in proceeds of $338,640. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 13.8K

21.03% 3M change

43.6% 12M change

Total Value Held $2.35 Million

R. Alexandra Keith Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Oct 22 2024	SELL Open market or private sale	$338,640 $170.0 p/Share	1,992 Reduced 12.63%	13,783 Common Stock
Oct 03 2024	SELL Open market or private sale	$286,921 $170.99 p/Share	1,678 Reduced 9.61%	15,775 Common Stock
Aug 23 2024	SELL Open market or private sale	$2,185,482 $170.05 p/Share	12,852 Reduced 42.41%	17,453 Common Stock
Aug 21 2024	SELL Open market or private sale	$1,812,859 $170.59 p/Share	10,627 Reduced 25.96%	30,305 Common Stock
Aug 19 2024	BUY Grant, award, or other acquisition	-	23,479 Added 36.51%	40,828 Common Stock
Aug 08 2024	SELL Open market or private sale	$712,081 $171.05 p/Share	4,163 Reduced 19.35%	17,349 Common Stock
Aug 05 2024	SELL Open market or private sale	$573,410 $170.0 p/Share	3,373 Reduced 13.55%	21,512 Common Stock
Nov 14 2023	SELL Open market or private sale	$3,017,373 $153.47 p/Share	19,661 Reduced 44.58%	24,438 Common Stock
Nov 14 2023	BUY Exercise of conversion of derivative security	$1,937,591 $98.55 p/Share	19,661 Added 30.84%	44,099 Common Stock
Oct 24 2023	SELL Open market or private sale	$280,200 $150.0 p/Share	1,868 Reduced 7.1%	24,438 Common Stock
Oct 02 2023	SELL Open market or private sale	$204,842 $144.97 p/Share	1,413 Reduced 5.1%	26,306 Common Stock
Aug 30 2023	SELL Open market or private sale	$817,055 $153.9 p/Share	5,309 Reduced 16.07%	27,719 Common Stock
Aug 24 2023	SELL Open market or private sale	$817,740 $154.0 p/Share	5,310 Reduced 13.85%	33,028 Common Stock
Aug 17 2023	SELL Open market or private sale	$1,385,279 $152.85 p/Share	9,063 Reduced 19.12%	38,338 Common Stock
Aug 16 2023	BUY Grant, award, or other acquisition	-	19,682 Added 29.34%	47,401 Common Stock
Apr 24 2023	SELL Open market or private sale	$1,055,683 $156.12 p/Share	6,762 Reduced 19.8%	27,387 Common Stock
Mar 01 2023	SELL Open market or private sale	$734,631 $137.34 p/Share	5,349 Reduced 13.54%	34,149 Common Stock
Dec 07 2022	SELL Payment of exercise price or tax liability	$14,470 $149.18 p/Share	97 Reduced 0.25%	39,241 Common Stock
Dec 07 2022	BUY Exercise of conversion of derivative security	$14,470 $149.18 p/Share	97 Added 0.25%	39,338 Common Stock
Nov 08 2022	SELL Open market or private sale	$4,668,561 $137.44 p/Share	33,968 Reduced 46.56%	38,990 Common Stock
Nov 08 2022	BUY Exercise of conversion of derivative security	$3,007,526 $88.54 p/Share	33,968 Added 42.13%	46,665 Common Stock
Oct 03 2022	BUY Grant, award, or other acquisition	-	3,777 Added 8.83%	38,990 Common Stock
Aug 18 2022	SELL Open market or private sale	$2,583,315 $148.92 p/Share	17,347 Reduced 33.0%	35,213 Common Stock
Aug 17 2022	SELL Open market or private sale	$2,169,765 $149.33 p/Share	14,530 Reduced 21.66%	52,560 Common Stock
Aug 16 2022	BUY Grant, award, or other acquisition	-	31,877 Added 32.21%	67,090 Common Stock

Also insider at

TMO

THERMO FISHER SCIENTIFIC INC. Healthcare

Director

RAK